Peritoneal Malignant Mesothelioma clinical trials

Explore recruiting peritoneal malignant mesothelioma clinical trials.

Recruiting peritoneal malignant mesothelioma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peritoneal Malignant Mesothelioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Peritoneal Malignant Mesothelioma trials by city

Peritoneal Malignant Mesothelioma in Toronto Peritoneal Malignant Mesothelioma in Vancouver Peritoneal Malignant Mesothelioma in Montreal Peritoneal Malignant Mesothelioma in Calgary Peritoneal Malignant Mesothelioma in Edmonton Peritoneal Malignant Mesothelioma in Ottawa Peritoneal Malignant Mesothelioma in Winnipeg Peritoneal Malignant Mesothelioma in Quebec City Peritoneal Malignant Mesothelioma in Hamilton Peritoneal Malignant Mesothelioma in Kitchener Peritoneal Malignant Mesothelioma in London Peritoneal Malignant Mesothelioma in Halifax Peritoneal Malignant Mesothelioma in New York Peritoneal Malignant Mesothelioma in Los Angeles Peritoneal Malignant Mesothelioma in Chicago Peritoneal Malignant Mesothelioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease